FDx Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,377
Closed -$202K 814
2021
Q1
$202K Buy
+6,377
New +$187K 0.01% 745
2015
Q4
Sell
-4,609
Closed -$822K 865
2015
Q3
$822K Sell
4,609
-887
-16% -$207K 0.07% 302
2015
Q2
$1.21M Buy
5,496
+596
+12% +$132K 0.06% 284
2015
Q1
$978K Buy
4,900
+879
+22% +$156K 0.02% 611
2014
Q4
$575K Buy
+4,021
New +$541K 0.04% 498
2014
Q3
Sell
-4,823
Closed -$608K 950
2014
Q2
$608K Sell
4,823
-694
-13% -$88.5K 0.04% 514
2014
Q1
$727K Sell
5,517
-927
-14% -$127K 0.06% 328
2013
Q4
$757K Sell
6,444
-5,609
-47% -$615K 0.08% 256
2013
Q3
$1.26M Sell
12,053
-151
-1% -$14.7K 0.15% 140
2013
Q2
$1.05M Buy
+12,204
New +$962K 0.14% 150

Other funds holding BHC

FDx Advisors's BHC Position: Q2 2021 in Review

FDx Advisors sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 6,377 shares — an estimated $202K sold.

FDx Advisors first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $1.26M in Q3 2013. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • FDx Advisors reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • FDx Advisors sold 6,377 Bausch Health shares in Q2 2021, an estimated $202K.
  • FDx Advisors first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
  • FDx Advisors's Bausch Health position peaked at $1.26M in Q3 2013.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on FDx Advisors's 13F filing for Q2 2021, filed 5 Aug 2021.